Apyx Medical Corp. (APYX) Misses Q4 EPS by 3c; Offers Guidance

Apyx Medical Corp. (NASDAQ: APYX) reported Q4 EPS of ($0.17), $0.03 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $12.61 million versus the consensus estimate of $12.94 million.

GUIDANCE:

Apyx Medical Corp. sees FY2023 revenue of $58-61 million, versus the consensus of $52.157 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Oxford Industries (OXM) Tops Q1 EPS by 12c; Offers Outlook
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance